Amira Pharmaceuticals, Inc.
Records under this name other than the patents Amira Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 18 patents it holds.
Back to Amira Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,977,359 | 5-lipdxygenase-activating protein (FLAP) inhibitors Formerly held Lapsed on the fee record Ended Jul 12, 2023 · USPTO record | Lapsed on the fee record | Ended Jul 12, 2023 | USPTO record |
| US 8,815,917 | DP2 antagonist and uses thereof Formerly held Lapsed on the fee record Ended Aug 26, 2022 · USPTO record | Lapsed on the fee record | Ended Aug 26, 2022 | USPTO record |
| US 8,772,495 | 5-lipoxygenase-activating protein inhibitor Formerly held Lapsed on the fee record Ended Jul 8, 2022 · USPTO record | Lapsed on the fee record | Ended Jul 8, 2022 | USPTO record |
| US 8,710,081 | 5-lipoxygenase-activating protein (FLAP) inhibitors Formerly held Lapsed on the fee record Ended Apr 29, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2022 | USPTO record |
| US 8,546,431 | 5-lipoxygenase-activating protein (FLAP) inhibitors Formerly held Lapsed on the fee record Ended Oct 1, 2021 · USPTO record | Lapsed on the fee record | Ended Oct 1, 2021 | USPTO record |
| US 8,399,666 | 5-lipoxygenase-activating protein (FLAP) inhibitors Formerly held Lapsed on the fee record Ended Mar 19, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 19, 2021 | USPTO record |
| US 9,572,785 | DP2 antagonist and uses thereof Formerly held Lapsed on the fee record Ended Feb 21, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 21, 2021 | USPTO record |
| US 8,362,044 | N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors Formerly held Lapsed on the fee record Ended Jan 29, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 29, 2021 | USPTO record |
| US 8,338,484 | N,N-disubstituted aminoalkylbiphenyl antagonists of prostaglandin D2 receptors Formerly held Lapsed on the fee record Ended Dec 25, 2020 · USPTO record | Lapsed on the fee record | Ended Dec 25, 2020 | USPTO record |
| US 8,247,602 | Antagonists of prostaglandin D2 receptors Formerly held Lapsed on the fee record Ended Aug 21, 2020 · USPTO record | Lapsed on the fee record | Ended Aug 21, 2020 | USPTO record |